MedTrace Logo

INJECTHEAL - Investigation of Chronic Wound Exudate and Biofilm

NCT07745764 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2026-08-04

No results posted yet for this study

Summary

This prospective observational study will collect routine clinical waste material from 72 adults with chronic, non-healing wounds, including wound exudate from negative pressure therapy containers or sponges and wound biofilm/debridement material. Samples and routine clinical wound data will be used to test INJECTHEAL hydrogel components and other wound healing therapeutics, and identify molecular, biochemical, and microbiological biomarkers linked to wound healing.

Conditions

  • Chronic Ulcers: Non-healing Deep Cavity Wounds (e.g., Diabetic Foot Ulcers, Arterial Ulcers, Post-surgical Wound Healing Disorders)

Interventions

OTHER

standard of care

Patients enrolled in this observational study receive standard of care. Treatment, ointments, compression and bandages will be registered at every visit.

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER

  • Barbara Wolff-Winiski

    lead INDUSTRY

Principal Investigators

  • Dr. Barbara Wolff-Winiski, MBA · Akribes/Biomedical GmbH, Dr. Bohr-Gasse 7 A-1030 Vienna, Austria

  • Dr. med. Julian-Dario Rembe, Ph.D. · Heinrich-Heine University, Duesseldorf; Moorenstr. 5 40225 Düsseldorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2028-04-10
Completion
2028-04-10

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07745764 on ClinicalTrials.gov